Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety profile of lacidipine: update from a clinical trials database.

× No keyword cloud information.

9 in total

1. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors: J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal: Lancet Date: 1997-09-13 Impact factor: 79.321

2. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report.

Authors: L H Lindholm; L Hansson; B Dahlöf; T Ekbom; T Hedner; U De Faire; B Scherstén; P O Wester
Journal: Blood Press Date: 1996-09 Impact factor: 2.835

3. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

Authors: C D Furberg; B M Psaty; J V Meyer
Journal: Circulation Date: 1995-09-01 Impact factor: 29.690

4. Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database.

Authors: L H Lindholm; P Tcherdakoff; A Zanchetti
Journal: J Hypertens Suppl Date: 1996-09

Review 5. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).

Authors: A Zanchetti
Journal: J Hypertens Suppl Date: 1995-12

6. The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability.

Authors: L Hansson; A Zanchetti
Journal: Blood Press Date: 1997-09 Impact factor: 2.835

7. The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors: B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272

Review 8. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors: R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal: Lancet Date: 1990-04-07 Impact factor: 79.321

9. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors: S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal: Lancet Date: 1990-03-31 Impact factor: 79.321

9 in total

3 in total

Safety profile of lacidipine: update from a clinical trials database.